Pfizer, BioNTech to Develop mRNA Shingles Vaccine

Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
More Videos
What to Expect at SXSW 2025
Fast Company's KC Ifeanyi reveals what's next as media, tech, and social collide. Cheddar's exclusive SXSW content airs March 12th and 14th at 8pm EST
Load More